| Literature DB >> 29031612 |
Jun Hirata1, Tomomitsu Hirota2, Takeshi Ozeki3, Masahiro Kanai4, Takeaki Sudo5, Toshihiro Tanaka6, Nobuyuki Hizawa7, Hidemi Nakagawa8, Shinichi Sato9, Taisei Mushiroda3, Hidehisa Saeki10, Mayumi Tamari11, Yukinori Okada12.
Abstract
Psoriasis vulgaris (PsV) is an autoimmune disease of skin and joints with heterogeneity in epidemiologic and genetic landscapes of global populations. We conducted an initial genome-wide association study and a replication study of PsV in the Japanese population (606 PsV cases and 2,052 controls). We identified significant associations of the single nucleotide polymorphisms with PsV risk at TNFAIP3-interacting protein 1and the major histocompatibility complex region (P = 3.7 × 10-10 and 6.6 × 10-15, respectively). By updating the HLA imputation reference panel of Japanese (n = 908) to expand HLA gene coverage, we fine-mapped the HLA variants associated with PsV risk. Although we confirmed the PsV risk of HLA-C*06:02 (odds ratio = 6.36, P = 0.0015), its impact was relatively small compared with those in other populations due to rare allele frequency in Japanese (0.4% in controls). Alternatively, HLA-A*02:07, which corresponds to the cysteine residue at HLA-A amino acid position 99 (HLA-A Cys99), demonstrated the most significant association with PsV (odds ratio = 4.61, P = 1.2 × 10-10). In addition to HLA-A*02:07 and HLA-C*06:02, stepwise conditional analysis identified an independent PsV risk of HLA-DQβ1 Asp57 (odds ratio = 2.19, P = 1.9 × 10-6). Our PsV genome-wide association study in Japanese highlighted the genetic architecture of PsV, including the identification of HLA risk variants.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29031612 DOI: 10.1016/j.jid.2017.10.001
Source DB: PubMed Journal: J Invest Dermatol ISSN: 0022-202X Impact factor: 8.551